CDC issues updated Hepatitis A immunization recommendations for United States population
Health officials issue new recommendations for hepatitis A vaccination in the United States
The CDC has published updated recommendations for Hepatitis A immunization in the United States population.
New guidelines update who should get vaccinated against hepatitis A to better prevent infections across the United States.
Hepatitis A outbreak cases reported across 26 states in observational data
Health officials report hepatitis A outbreak cases across 26 states
An observational report describes hepatitis A outbreak cases reported from 26 states.
Hepatitis A cases are spreading across 26 states as public health officials track the outbreak.
Hepatitis A outbreak reported in the United States, details on scope and response not provided
Hepatitis A outbreak reported in the United States, details remain limited
A report describes a Hepatitis A outbreak in the United States.
Health authorities have announced a Hepatitis A outbreak is occurring in the United States, though specific details about locations or cause…
Report describes hepatitis A outbreak-related deaths in the United States
Report examines hepatitis A outbreak deaths in the United States
A report describes deaths related to hepatitis A outbreaks in the United States.
A new report describes deaths related to hepatitis A outbreaks in the United States, though key details about the study remain unavailable.
Surveillance report tracks drinking water-associated hepatitis A outbreaks from 1971 to 2017
U.S. tracked drinking water hepatitis A outbreaks for decades, report shows
A surveillance report from the Waterborne Disease and Outbreak Surveillance System tracked drinking water-associated hepatitis A outbreaks i…
A public health report tracks U.S. drinking water hepatitis A outbreaks from 1971 to 2017, serving as a record of incidents reported to the …
Hepatitis A infection reports increased 294% in the United States during 2016-2018
Hepatitis A infection reports increased sharply in the United States over recent years
An observational study in the United States found a 294% increase in hepatitis A infection reports during 2016-2018 compared with 2013-2015.
Reports of hepatitis A infections in the United States more than tripled between 2013 and 2018, rising by 294% in just three years.
Molecular testing used during hepatitis A outbreak investigation in Los Angeles County
How do health officials track a hepatitis A outbreak?
An outbreak investigation report describes the use of molecular testing during a hepatitis A outbreak in Los Angeles County, California.
Public health officials in Los Angeles County used molecular testing to track a hepatitis A outbreak and link cases together.
Field report notes increased hepatitis A virus concentrations in Los Angeles County wastewater during outbreak
Hepatitis A virus levels rose in Los Angeles wastewater during an outbreak
An observational field report from Los Angeles County, California, documented a significant increase in hepatitis A virus concentrations in …
Hepatitis A virus levels rose sharply in Los Angeles wastewater during a recent outbreak, confirming the virus was circulating more in the c…
Research across Hepatitis
Related studies from across the Hepatitis family.
Elevated serum M2BPGi is associated with a 4.61 hazard ratio for hepatocellular carcinoma development
Elevated M2BPGi Levels Linked to Higher Risk of Liver Cancer
This systematic review and meta-analysis of 12,161 participants found that elevated serum M2BPGi is significantly associated with an increas…
A large review of over 12,000 patients found that high levels of a specific protein may signal an increased risk for liver cancer.
Dolutegravir and lamivudine achieved 78% HIV-1 RNA suppression in patients with isolated reactive anti-HBc
Trial shows dolutegravir and lamivudine are safe for patients with HIV
This pooled analysis of Phase 3/3b trials evaluated dolutegravir/lamivudine (DTG/3TC) in adults with HIV-1 and isolated reactive hepatitis B…
A review of multiple trials shows that a common two-drug regimen effectively manages HIV while remaining safe for those with hepatitis B ant…
Susceptibility-guided combination therapy improves neurological status and reduces abscess size in a patient with nocardiosis
Case report: Brain infection in autoimmune hepatitis patient
This case report describes the management of disseminated nocardiosis in a 55-year-old man with autoimmune hepatitis. The patient showed gra…
A man with autoimmune hepatitis developed a rare brain infection after immunosuppression. Doctors treated it successfully with targeted anti…
Direct-acting antivirals achieve 89% sustained virologic response in patients with hepatocellular carcinoma and HCV
Direct-acting antivirals show promise for patients with liver cancer
This meta-analysis of 8,839 patients with hepatocellular carcinoma (HCC) and Hepatitis C virus infection found that direct-acting antivirals…
New data suggests that direct-acting antiviral drugs may improve survival and reduce cancer recurrence for people with Hepatitis C and liver…
JAK inhibitors are associated with higher hepatitis B virus reactivation rates than IL-12/23 or IL-17 inhibitors
Specific Immune Inhibitors Show Varying Risks for Hepatitis B Reactivation
This meta-analysis of 29 studies evaluated the risk of hepatitis B virus reactivation (HBVr) in patients receiving various immunomodulators.…
New analysis shows that certain immune inhibitors like JAK inhibitors may carry a higher risk of hepatitis B reactivation than other drug cl…
HBeAg seroclearance in HBeAg-positive chronic hepatitis B correlates with disease remission and reduced hepatocellular carcinoma risk
Clearing HBeAg helps manage chronic hepatitis B and liver risk
This systematic review examines the clinical significance and optimization strategies of HBeAg seroclearance in patients with HBeAg-positive…
Achieving HBeAg seroclearance in patients with chronic hepatitis B can lead to disease remission and a lower risk of developing liver cancer…
Autoimmune hepatitis pathogenesis shifts from single molecule to immune-metabolic network analysis
New Research Maps Complex Networks in Autoimmune Hepatitis
This systematic review reframes autoimmune hepatitis (AIH) pathogenesis from a single-molecule perspective to a systematic regulatory networ…
Researchers are moving beyond single-molecule views to map complex immune and metabolic networks that drive autoimmune hepatitis.
Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes
Digital health tools show mixed results for managing chronic diseases
Digital tools show promise for heart failure monitoring but lack consistent evidence for improving medication adherence or general diabetes …
New data shows that while digital tools like apps can help heart failure patients monitor their health, they may not improve medication habi…
Epigallocatechin-3-gallate shows positive therapeutic effects on various digestive system diseases in animal models
Green tea compound shows potential for several digestive diseases
This meta-analysis of 63 preclinical studies involving 738 animals indicates that Epigallocatechin-3-gallate (EGCG) has a positive therapeut…
A review of animal studies suggests a green tea compound could help treat various cancers and digestive conditions.
HLA-B*57:01-guided abacavir prescribing is the clearest preventive paradigm from HLA associations
HLA genes shape HIV and hepatitis vaccine responses and drug reactions
This narrative review examines HLA polymorphisms in HIV, hepatitis C, and hepatitis B. The clearest preventive paradigm is HLA-B*57:01-guide…
A review finds that HLA genes strongly influence how people respond to HIV and hepatitis vaccines and how they react to certain medications.
PEG-IFN plus novel agents may boost functional cure in chronic hepatitis B
Combination therapies may improve functional cure rates for chronic hepatitis B
This narrative review examines combining pegylated interferon-α with novel immunotherapies (antigen-reduction strategies, therapeutic vaccin…
A review suggests combining pegylated interferon with new immunotherapies could help achieve functional cure in chronic hepatitis B patients…
Chronic HCV infection drives T cell dysfunction, regulatory T cell accumulation, and metabolic defects that persist after viral clearance
Immune defects in hepatitis C may last after the virus is gone
This narrative review examines immune mechanisms in patients with chronic hepatitis C virus infection. The authors describe how prolonged an…
A review explains how chronic hepatitis C causes lasting immune changes that persist even after the virus is cleared, suggesting new treatme…
Questions about Hepatitis A
What details are available about the recent Hepatitis A outbreak in the United States?
Recent data shows a sharp rise in Hepatitis A cases across the U.S., with outbreaks linked to contaminated food, water, and specific geographic areas like Los Angeles County.
Full answer →What role did molecular testing play in the Los Angeles County Hepatitis A outbreak?
Molecular testing identified the specific strain of the virus in Los Angeles County, confirming the outbreak was caused by a single source and allowing officials to trace the spread to wastewater contamination.
Full answer →What are the new Hepatitis A immunization recommendations for the United States?
New recommendations focus on vaccinating adults at risk, including those who use drugs, are homeless, or have chronic liver disease, due to a major shift in how the virus spreads.
Full answer →